Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent

23-Jun-2008 - Artecel, Inc., announced that the patent inventorship litigation concerning the foundational, composition-of-matter patent covering stem cells isolated from adipose (fat) tissue has been decided in favor of Artecel's licensor, the University of Pittsburgh and against Cytori Therapeutics' ...

Cytori's Celution System Under Evaluation for Breast Augmentation as Part of Investigator Initiated Study

08-Nov-2007 - A new study underway in Japan will examine the effect of adult stem and regenerative cells derived from adipose tissue in breast augmentation. In this investigational procedure, a patient's breast is augmented with her own liposuctioned fat, which has been combined and enhanced with her own ...

Cytori awarded NIH Grant to develop cell-based treatments for vascular disease

21-Sep-2007 - Cytori Therapeutics was awarded a $250,000 NIH (National Institutes of Health) Grant to develop adipose-derived regenerative cells as a treatment for vascular disease. Regenerative cells within adipose (fat) tissue include adult stem cells and other cell types that have been shown to increase ...

Invitrogen Partners with Cytori to Offer Adipose Stem Cell Research Products

10-May-2007 - Invitrogen Corporation and Cytori Therapeutics entered into a global strategic supply and commercialization agreement to offer adipose-derived stem cell-based research products to life science researchers. Invitrogen will offer Cytori's stem cell products to broaden the understanding of adult ...

Cytori Forms Stem Cell Therapy Distribution Partnership in Spain, Italy and Portugal

22-Feb-2007 - Cytori Therapeutics entered into an agreement with MBA Grupo, a European healthcare distributor, who will distribute the Celution(TM) System in Spain, Italy and Portugal starting early 2008 for reconstructive surgery applications. MBA Grupo will oversee product sales, education and training for ...

First Heart Patient Treated in Adipose Stem Cell Trial

Cytori's Cardiovascular Stem Cell Study Initiated

08-Feb-2007 - Cytori Therapeutics and Hospital Gregorio Maranon in Madrid, Spain treated the first patient in Cytori's randomized clinical trial investigating the safety and feasibility of adipose-derived stem and regenerative cells as a therapy for cardiovascular disease. The study, designated as the ...

Cytori to Begin Stem Cell Trial for Heart Disease

05-Jan-2007 - Cytori Therapeutics received approvals to initiate a clinical trial in Spain to investigate the use of adipose-derived stem and regenerative cells for the treatment of cardiovascular disease. The cells will be obtained at the bedside from the patients' own adipose (fat) tissue and made available ...

Cambrex Corporation and Cytori Therapeutics Enter Into Collaboration to Provide Adipose Derived Stem Cell Research Products

16-Jun-2006 - Cambrex Bio Science Walkersville, Inc., a subsidiary of Cambrex Corporation, and Cytori Therapeutics announced that they have entered into a strategic marketing agreement to provide adipose-derived stem cell products globally for use in basic and translational bioresearch. Under the terms of the ...

Cytori Therapeutics Demonstrates Adipose Stem and Regenerative Cells Reduce Incidence of Arrhythmia after Heart Attacks

25-Apr-2006 - Cytori Therapeutics, Inc. announced preclinical data demonstrating that adipose stem and regenerative cell-based therapy following a heart attack in pigs is not associated with an increased risk of irregular heart rhythms, which can result in potentially life threatening complications from heart ...

Adipose-Derived Stem Cells Improved Left Ventricle Wall Thickness and Capillary Density in Pigs Following Myocardial Infarction

16-Mar-2006 - Cytori Therapeutics, Inc. announced that adipose-derived stem cells improved left ventricle wall thickness and capillary density following myocardial infarction in a randomized, placebo-controlled preclinical study. The study, conducted at Tulane University, involved administering fresh ...